|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | From complex sys- tems analysis to transformational change:a comparative appraisal of sustainability science projects 显示文摘 | WIEK A NESS B SCHWEIZER-RIES P | 2012 | Sustainability Science2012，7，1： | 1 |
| 2 | Current practice in surveillance strategy for patients with Barrett's esophagus in the UK显示文摘 | Mandal A Playford R J Wieks A C | 2003 | Aliment Pharmacol Ther2003，17，10： | 1 |
| 3 | Synthesis of paullones with aminoalkyl side chains显示文摘 | WIEKING K KNOCKAERT M LEOST M | 2002 | Arch Pharm (Weinheim)2002，335，： | 1 |
| 4 | Retinal blood flow in diabetic retinopathy显示文摘 | Rassam S Newsom R Wiek J | 1992 | Br Med J1992，305，： | 1 |
| 5 | Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDKS, and GSK-3 inhibition by paullones显示文摘 | KUNICK C LAUENROTH K WIEKING K | 2004 | J Med Chem2004，47，： | 1 |
| 6 | Germline muta- tions in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene显示文摘 | Meindl A Hellebrand H Wiek C | 2010 | Nat Genet2010，42，5： | 1 |
| 7 | Hyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome 显示文摘 | Undas A Wiek I Stepien E | 2008 | Diabetes Care2008，31，8： | 1 |
| 8 | Hyperglycemia is associated with enhance thrembin formation platelet activation and fibrin clot resistance to lysis in patients with acute coronary syndrome 显示文摘 | Undas A Wiek 1 St8pien E | 2008 | Diabetes Care2008，31，： | 1 |
| 9 | Evaluation and comparison of 3D-QSAR CoMSIA models for CDK1, CDK5, and GSK-3 inhibition by paullones显示文摘 | KUNICK C LAUENROTH K WIEKING K | 2004 | J Med Chem2004，47，1： | 1 |
| 10 | Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene显示文摘 | Meindl A Hellebrand H Wiek C | | Nat Genet0，42，5： | 1 |
| 11 | Pathophysiologic and Therapeutic Importance of Tissue ACE: A Consensus Report显示文摘 | Victor J. Dzau Kenneth Bernstein David Celermajer Jerome Cohen Bj?rn Dahl?f John Deanfield Javier Diez Helmut Drexler Roberto Ferrari Wiek van Gilst Lennart Hansson Burkhard Hornig Ahsan Husain Colin Johnston Harold Lazar Eva Lonn Thomas Lüscher John Manc | 2002 | Cardiovascular Drugs and Therapy2002，，2： | 1 |
| 12 | Rabbit colony infected with a bovine-like G6P[11] rotavirus strain显示文摘 | Esther Schoondermark-van de Ven Marc Van Ranst Wieke de Bruin Patrick van den Hurk Mark Zeller Jelle Matthijnssens Elisabeth Heylen | 2013 | Veterinary Microbiology . 2013 (1-2)2013，，1： | 1 |
| 13 | Inhibition of Candida albicans biofilm formation by farnesol, a quorum sensing molecule显示文摘 | Ramage G Saville SP Wiekes BL | 2002 | Applied and Environmental Microbiology2002，68，11： | 1 |
| 14 | Growth hormone therapy in patients with cirrhosis: a pilot study of efficacy and safety 显示文摘 | Donaghy A Ross R Wieks C | 1997 | Gastroenterology1997，113，： | 1 |
| 15 | C-reactive protein and microalbuminuria are associated with atrial fibrillation显示文摘 | Folkert W. Asselbergs Maarten P. van den Berg Gilles F.H. Diercks Wiek H. van Gilst Dirk J. van Veldhuisen | 2004 | International Journal of Cardiology2004，，： | 1 |
| 16 | Germline mutations in breast and ovarian cancer pedigrees establish P, AD51C as a human cancer susceptibility gene显示文摘 | Meindl A Hellebrand H Wiek C | | Nat Genet0，42，5： | 1 |
| 17 | Evaluation of Cladribine treatment in refractory celiac disease type Ⅱ显示文摘AIM: To evaluate cladribine [2-chlorodeoxyadenosine (2-CdA)] therapy in refractory celiac disease (RCD) Ⅱ. METHODS: An open-label cohort-study of RCD Ⅱ patients treated with 2-CdA was performed between 2000 and 2010. Survival rate, enteropathy associated T-cell lymphoma (EATL) occurrence, clinical course, and histological and immunological response rates were evaluated. RESULTS: Overall, 32 patients were included with a median follow-up of 31 mo. Eighteen patients responded well to 2-CdA. Patients responsive to 2-CdA had a statistically significant increased survival compared to those who were unresponsive. The overall 3- and 5-year survival was 83% in the responder and 63% and 22% in the non-responder group, respectively. The overall 2-year clinical, histological and immunological response rates were 81%, 47% and 41%, respectively. Progression into EATL was reported in 16%, all of these patients died. CONCLUSION: Treatment of RCD Ⅱ with 2-CdA holds promise, showing excellent clinical and histological response rates, and probably less frequent transition into EATL. | Greetje J Tack Wieke HM Verbeek Abdul Al-Toma Dirk J Kuik Marco WJ Schreurs Otto Visser Chris JJ Mulder | 2011 | World Journal of Gastroenterology2011，17，4： | 1 |
| 18 | Mutations of the human homolog of Drosophila patched in the nevoid basal cell car- cinoma syndrome显示文摘 | Hahn H Wieking C Zaphiropoulous PG | 1996 | Cell1996，85，6： | 1 |
| 19 | A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors显示文摘 | Wieking BG Vermeer DW Spanos WC | 2012 | Cancer Gene Ther2012，19，1： | 1 |
| 20 | The effects of polymorphisms in genes from the renin–angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context显示文摘 | Folkert W. Asselbergs Scott M. Williams Patricia R. Hebert Christopher S. Coffey Hans L. Hillege Harold Snieder Gerjan Navis Douglas E. Vaughan Wiek H. Gilst Jason H. Moore | 2007 | Human Genetics (-)2007，，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员